Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Injectable platelet-rich fibrin with a minimally invasive non-surgical technique for treating intrabony periodontal defects

Official title: Injectable Platelet-Rich Fibrin (i-PRF) With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defects: A Randomized Clinical Trial

Run by October 6 University · NCT07613606 · Data updated 2026-11-12

This study tests whether adding injectable platelet-rich fibrin to a minimally invasive non-surgical treatment helps regenerate bone in intrabony periodontal defects.

More Intrabony Periodontal Defect trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorOctober 6 University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedMay 29, 2026
Trial IDNCT07613606 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with periodontitis stage III (grades B or C) having single-rooted or multi-rooted teeth with bilateral two- or three-walled intrabony defects and no systemic conditions affecting periodontal healing.

Probably not a fit

Patients with systemic diseases, tobacco use, recent periodontal surgery, or other exclusion criteria may not experience additional benefit from the adjunctive i-PRF approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the adjunctive use of injectable platelet-rich fibrin (i-PRF) with a minimally invasive non-surgical technique (MINST) for regenerative treatment of intrabony periodontal defects. Participants are adults with periodontitis stage III (grades B or C), with bilateral comparable intrabony defects. The approach combines MINST to debride the defect with i-PRF to potentially enhance tissue regeneration, monitored clinically and radiographically. The study emphasizes soft tissue preservation and primary wound closure as key factors for optimal regeneration. Outcomes will inform whether i-PRF adds benefit over MINST alone in promoting periodontal regeneration.

Why it matters

Potential benefit: If successful, patients may experience better regeneration of bone and supporting tissues around affected teeth with a less invasive procedure.

How similar studies have gone: Previous approaches using biologics like platelet-rich products have shown regenerative potential in periodontal defects, but results vary and this combination with MINST is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of both genders \>18 years old, medically free of systemic diseases affecting periodontal regeneration.
* Diagnosis of 'periodontitis' stage III (grades B or C).
* Single-rooted and multi-rooted vital teeth in either the maxilla or the mandible.
* Presence of comparable bilateral two- or three-walled intrabony defects \[probing pocket depth (PPD), \> 5 mm with intrabony defect depth ≥ 3 mm, from the alveolar crest to the defect base, at screening radiograph\] not in a furcation-involved tooth.

Exclusion Criteria:

* Patients with systemic illness known to affect the outcome of periodontal therapy, including diabetes, immune deficiencies, etc.
* Pregnant and lactating women
* Current use of any form of tobacco.
* Non-surgical periodontal treatment in the past 6 months, or surgical periodontal treatment in the past 12 months.
* Degree 2 or 3 mobility of the involved sites.6.
* Presence of periapical pathology, acute infection, or subgingival restoration which could interfere with clinical measurements.

Where it's running

  • October 6 University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.